This site became the new ClinicalTrials.gov on June 19th. Learn more.
Show more
ClinicalTrials.gov Menu IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more...
ClinicalTrials.gov Menu IMPORTANT: Talk with a trusted healthcare professional before volunteering for a study. Read more...
ClinicalTrials.gov Menu
Give us feedback

Abciximab for Prevention of Stroke Recurrence Before Endarterectomy in Symptomatic Carotid Stenosis

This study has been terminated.
(Higher hemorrhage rates of Abciximab in ABESST II trial)
Sponsor:
Collaborators:
Schweizerische Herzstiftung
Eli Lilly and Company
Information provided by:
University of Zurich
ClinicalTrials.gov Identifier:
NCT00126139
First received: July 29, 2005
Last updated: May 1, 2007
Last verified: May 2007
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been terminated.
  Study Completion Date: May 2005
  Primary Completion Date: No date given